-
Drug Safety Newsletter – Edition 112 – 9 June 2023
Jun 9, 2023, 00:00 -
Fluphenazin-neuraxpharm D25 Solution for Injection (Exempt Medicinal Product) – Pharmacy level recall – One batch
Jun 8, 2023, 14:46 -
PRAC meeting highlights 5-8 June 2023
Jun 5, 2023, 00:00 -
Veterinary medicines containing the excipient NMP – Potential risks of developmental toxicity
Apr 6, 2023, 00:00 -
Nurofen Plus – MIMS – Serious clinical harms with higher than recommended doses
Dec 1, 2022, 00:00 -
Drug Safety Newsletter – Edition 109 – 10 November 2022
Nov 10, 2022, 00:00 -
Nurofen Plus – Warning on prolonged use at higher than recommended doses
Oct 21, 2022, 00:00 -
Topamax (topiramate) – Ongoing EU review of potential risk of NDD
Oct 18, 2022, 00:00 -
Drug Safety Newsletter – Edition 108 – 10 August 2022
Aug 10, 2022, 00:00 -
Genrui SARS-CoV-2 Antigen Self-Test Kit (Colloidal Gold) – Priority 1 – For Immediate Action
Jan 18, 2022, 00:00
